PMA P110033

Device: SKINVIVE by JUVEDERM®
Applicant: Allergan
PMA number: P110033
Supplement: S067
Product code: LMH
Decision date: 2026-06-11
Generic name: Implant, dermal, for aesthetic use
Approval order statement: SKINVIVE by JUVÉDERM® is indicated for intradermal injection to improve skin smoothness of the cheeks and intradermal and/or subdermal injection to reduce neck lines for improvement of neck appearance in adults over the age of 21

Current openFDA PMA Record#

Device: SKINVIVE by JUVEDERM®
Applicant: Allergan
PMA number: P110033
Supplement: S099
Product code: LMH
Generic name: Implant, dermal, for aesthetic use
Decision date: 2026-06-11
Decision code: APPR
Date received: 2025-05-13
Supplement type: Panel Track
Supplement reason: Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement: SKINVIVE by JUVÉDERM® is indicated for intradermal injection to improve skin smoothness of the cheeks and intradermal and/or subdermal injection to reduce neck lines for improvement of neck appearance in adults over the age of 21